Yan Jia

Tianjin Key Laboratory Of Molecular Drug Research
Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Retraction notice to "Circ_0084653 promotes the tumor progression and immune escape in triple-negative breast cancer via the deubiquitination of MYC and upregulation of SOX5" [International Journal of Biological Macromolecules 280 (2024) 135655].

Retraction notice to "Circ_0084653 promotes the tumor progression and immune escape in triple-negative breast cancer via the deubiquitination of MYC and upregulation of SOX5" [International Journal of Biological Macromolecules 280 (2024) 135655].

Journal: International journal of biological macromolecules

Published: July 21, 2026

oHSV-1-modulated m6A methylation reprogramming through ALKBH5-mediated suppression of CARM1 induced apoptosis in glioblastoma.

oHSV-1-modulated m6A methylation reprogramming through ALKBH5-mediated suppression of CARM1 induced apoptosis in glioblastoma.

Journal: Virology journal

Published: March 19, 2026

Comparative effectiveness of CDK4/6 inhibitor plus endocrine therapy combinations in HR-positive, HER2-negative metastatic breast cancer: the inspiration 01 study.

Comparative effectiveness of CDK4/6 inhibitor plus endocrine therapy combinations in HR-positive, HER2-negative metastatic breast cancer: the inspiration 01 study.

Journal: Frontiers in pharmacology

Published: November 30, 2025

Intratumor Mycoplasma promotes the initiation and progression of hepatocellular carcinoma.

Intratumor Mycoplasma promotes the initiation and progression of hepatocellular carcinoma.

Journal: Cell reports

Published: January 29, 2025

Correction: Knockdown of THOC1 reduces the proliferation of hepatocellular carcinoma and increases the sensitivity to cisplatin.

Correction: Knockdown of THOC1 reduces the proliferation of hepatocellular carcinoma and increases the sensitivity to cisplatin.

Journal: Journal of experimental & clinical cancer research : CR

Published: October 13, 2024

Circ_0084653 promotes the tumor progression and immune escape in triple-negative breast cancer via the deubiquitination of MYC and upregulation of SOX5.

Circ_0084653 promotes the tumor progression and immune escape in triple-negative breast cancer via the deubiquitination of MYC and upregulation of SOX5.

Journal: International journal of biological macromolecules

Published: July 18, 2024

PD-1 inhibitor sintilimab treated patients with metastatic triple-negative breast cancer.

PD-1 inhibitor sintilimab treated patients with metastatic triple-negative breast cancer.

Journal: Frontiers in cell and developmental biology

Published: May 09, 2024

HBV DNA polymerase upregulates the transcription of PD-L1 and suppresses T cell activity in hepatocellular carcinoma.

HBV DNA polymerase upregulates the transcription of PD-L1 and suppresses T cell activity in hepatocellular carcinoma.

Journal: Journal of translational medicine

Published: December 04, 2023

Intratumor Mycoplasma promotes the initiation and progression of hepatocellular carcinoma.

Intratumor Mycoplasma promotes the initiation and progression of hepatocellular carcinoma.

Journal: Cell reports

Published: June 14, 2023

PKCζ phosphorylates VASP to mediate chemotaxis in breast cancer cells.

PKCζ phosphorylates VASP to mediate chemotaxis in breast cancer cells.

Journal: Experimental cell research

Published: June 02, 2023

CRSExtractor: Automated configuration option read sites extraction towards IoT cloud infrastructure.

CRSExtractor: Automated configuration option read sites extraction towards IoT cloud infrastructure.

Journal: Heliyon

Published: February 15, 2023

RNA N6-methyladenosine modification mediates downregulation of NR4A1 to facilitate malignancy of cervical cancer.

RNA N6-methyladenosine modification mediates downregulation of NR4A1 to facilitate malignancy of cervical cancer.

Journal: Cell & bioscience

Published: August 31, 2022

Showing 1-12 of 33

Last Updated: 09/26/2026